Drawing for NITROGLYN

USPTO serial 73094009

NITROGLYN

Reviewed by CopyMark Law Group

Reg. 1060592Status 900
Filing date
Status date
Registration date
Mar 8, 1977
Examiner
—
Law office
SCANNING ON DEMAND

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NITROGLYN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

DAVID H E BURSIK

LINDA M BYRNE CRAWFORD MAUNU PLLC1270 NORTHLAND DR STE 390SAINT PAUL, MN 55120UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005NITROGLYCERIN TABLETSEXPIREDNov 6, 1953

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 5, 2008ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Feb 6, 2008ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 15, 2007CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Nov 7, 2007CFITCASE FILE IN TICRS—
Feb 27, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 17, 1997RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Mar 7, 19979.AFREGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8—
Nov 19, 1987CMMPMISCELLANEOUS PAPER—
Oct 13, 1987CMMPMISCELLANEOUS PAPER—
Jun 21, 1982C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—

Frequently asked questions

Related guidance